Loading
PZ Cormay S.A. Stock: price and insider trades · Poland
PZ Cormay S.A.: what insiders have been doing
We have very little insider data for PZ Cormay S.A. so far: the most recent filing dates from 18 May 2026. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by KNF and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 22,365 of 26,284 companies
26.4
score / 100
Value21
Quality32
FCF yld-6.0%
Earn yld-9.7%
EV/EBITDA18.4x
ROE-9.8%
Gross mgn39%
Net mgn-4.3%
Debt/EBITDA3.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
PLN 0.51
Analyst consensus
Income statement
RevenuePLN 96.3M
Gross profitPLN 37.9M39% margin
EBITDAPLN 2.9M3% margin
Net income-PLN 4.2M-4.5% margin
Valuation
P/Book1.0x
Beta-0.09
Balance sheet & cash
Market capPLN 42.9M
Total debtPLN 10.2M
Free Cash Flow-PLN 2.6M
Debt / Equity37%
Profitability & ownership
ROE-9.8%
ROA-1.6%
% institutions19.0%
Last declaration on 18 May 2026
Declarations1 total
●
Executives
0KNF
1 of 1 declaration
About PZ Cormay S.A.
PZ Cormay S.A. is a Polish company operating in the healthcare and pharmaceutical sector. It focuses on the development and production of medical devices and reagents for medical laboratory analyses.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
